DK1551867T3 - Anvendelse af poly-alfa-2,8-sialsyre-mimetiske peptider til modulering af NCAM-funktioner - Google Patents
Anvendelse af poly-alfa-2,8-sialsyre-mimetiske peptider til modulering af NCAM-funktionerInfo
- Publication number
- DK1551867T3 DK1551867T3 DK03769800.8T DK03769800T DK1551867T3 DK 1551867 T3 DK1551867 T3 DK 1551867T3 DK 03769800 T DK03769800 T DK 03769800T DK 1551867 T3 DK1551867 T3 DK 1551867T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- peptide
- sialic acid
- peptide complex
- poly
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 102000001068 Neural Cell Adhesion Molecules Human genes 0.000 title 1
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20020292548 EP1411061A1 (en) | 2002-10-16 | 2002-10-16 | Poly-alpha2,8-sialic acid mimetic peptides and their application |
| PCT/IB2003/005108 WO2004035609A2 (en) | 2002-10-16 | 2003-10-16 | Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1551867T3 true DK1551867T3 (da) | 2011-06-20 |
Family
ID=32039233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03769800.8T DK1551867T3 (da) | 2002-10-16 | 2003-10-16 | Anvendelse af poly-alfa-2,8-sialsyre-mimetiske peptider til modulering af NCAM-funktioner |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7417025B2 (da) |
| EP (3) | EP1411061A1 (da) |
| JP (2) | JP2006516186A (da) |
| AT (1) | ATE490973T1 (da) |
| AU (1) | AU2003278501A1 (da) |
| CA (1) | CA2501994A1 (da) |
| DE (1) | DE60335278D1 (da) |
| DK (1) | DK1551867T3 (da) |
| ES (1) | ES2359810T3 (da) |
| PT (1) | PT1551867E (da) |
| WO (1) | WO2004035609A2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1411061A1 (en) * | 2002-10-16 | 2004-04-21 | Centre National De La Recherche Scientifique (Cnrs) | Poly-alpha2,8-sialic acid mimetic peptides and their application |
| EP2724723A1 (en) | 2012-10-25 | 2014-04-30 | Universitätsklinikum Hamburg-Eppendorf | Tegaserod for use in the treatment of nerve injuries |
| CN103940985A (zh) * | 2014-04-10 | 2014-07-23 | 首都医科大学 | 研究脑内源性神经干细胞迁移、增殖、分化的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346512B1 (en) * | 1996-07-12 | 2002-02-12 | Mcgill University | Compounds and methods for modulating cell adhesion |
| JP4150082B2 (ja) * | 1996-08-27 | 2008-09-17 | カイロン コーポレイション | 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用 |
| DE60038955D1 (de) * | 1999-03-15 | 2008-07-03 | Univ Maryland | AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47 |
| US20030228301A1 (en) * | 2000-10-24 | 2003-12-11 | Li Li | Novel human proteins, polynucleotides encoding them and methods of using the same |
| EP1411061A1 (en) * | 2002-10-16 | 2004-04-21 | Centre National De La Recherche Scientifique (Cnrs) | Poly-alpha2,8-sialic acid mimetic peptides and their application |
-
2002
- 2002-10-16 EP EP20020292548 patent/EP1411061A1/en not_active Withdrawn
-
2003
- 2003-10-16 WO PCT/IB2003/005108 patent/WO2004035609A2/en active Search and Examination
- 2003-10-16 EP EP03769800A patent/EP1551867B1/en not_active Expired - Lifetime
- 2003-10-16 DK DK03769800.8T patent/DK1551867T3/da active
- 2003-10-16 DE DE60335278T patent/DE60335278D1/de not_active Expired - Lifetime
- 2003-10-16 EP EP10011987A patent/EP2295568A3/en not_active Withdrawn
- 2003-10-16 PT PT03769800T patent/PT1551867E/pt unknown
- 2003-10-16 AT AT03769800T patent/ATE490973T1/de not_active IP Right Cessation
- 2003-10-16 JP JP2004544626A patent/JP2006516186A/ja active Pending
- 2003-10-16 US US10/531,701 patent/US7417025B2/en not_active Expired - Fee Related
- 2003-10-16 ES ES03769800T patent/ES2359810T3/es not_active Expired - Lifetime
- 2003-10-16 AU AU2003278501A patent/AU2003278501A1/en not_active Abandoned
- 2003-10-16 CA CA002501994A patent/CA2501994A1/en not_active Abandoned
-
2008
- 2008-07-18 US US12/176,008 patent/US8048858B2/en not_active Expired - Fee Related
-
2010
- 2010-08-09 JP JP2010178921A patent/JP2011016810A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2359810T3 (es) | 2011-05-27 |
| US7417025B2 (en) | 2008-08-26 |
| EP1551867B1 (en) | 2010-12-08 |
| WO2004035609A3 (en) | 2004-08-26 |
| ATE490973T1 (de) | 2010-12-15 |
| AU2003278501A8 (en) | 2004-05-04 |
| EP2295568A3 (en) | 2011-04-20 |
| EP1551867A2 (en) | 2005-07-13 |
| EP2295568A8 (en) | 2011-10-26 |
| EP1411061A1 (en) | 2004-04-21 |
| DE60335278D1 (de) | 2011-01-20 |
| JP2011016810A (ja) | 2011-01-27 |
| EP2295568A2 (en) | 2011-03-16 |
| US20090105131A1 (en) | 2009-04-23 |
| WO2004035609A2 (en) | 2004-04-29 |
| US20060122108A1 (en) | 2006-06-08 |
| US8048858B2 (en) | 2011-11-01 |
| PT1551867E (pt) | 2011-03-14 |
| AU2003278501A1 (en) | 2004-05-04 |
| CA2501994A1 (en) | 2004-04-29 |
| JP2006516186A (ja) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE312119T1 (de) | Glucagonähnliche peptide, zusammensetzungen und verfahren | |
| NO20063026L (no) | Antistoffer | |
| NO995002D0 (no) | Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF-<alfa>-molekyler og DNA | |
| NO20043891L (no) | Anti-A-beta-antistoffer og deres anvendelse | |
| EA200201121A1 (ru) | Модуляторы рецепторов паратироидного гормона и родственного паратироидному гормону белка | |
| PL2058323T3 (pl) | Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC | |
| BR9507594A (pt) | Processo para o tratamento de glomerulonefrite em um paciente necessitado deste tratamento artigo de fabricação anticorpo hibridoma 5g.1;1 molécula deácido nucleico proteina isolada polipeptideo isolado vetor de ácido nucleico célula hospedeira recombinante processo para produzir um polipeptideo de anticorpo c5 isolado anticorpo anti-c5 isolado processo para produzir uma proteina de anticorpo anti-c5 isolado molécula de ácido nucleico isolada processo para produzir um anticorpo anti-c5 anticorpo anti-c5 fragmento 5g46k fragmento 5g27k peptideo 5g325aa isolado peptideo 5g200aa isolado oligopeptideo isolado processo para induzir um animal a produzir um anti-c5 processo para identificar um anticorpo anti-c5 e processo para tratar um paciente necessitado de inibiçao complemetar | |
| DE69129865T2 (de) | Osteogene peptide | |
| ECSP055849A (es) | Anticuerpo ("11c7") anti-nogo a y su uso farmacéutico | |
| DE69839566D1 (de) | Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten | |
| ATE371671T1 (de) | Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente | |
| ATE256185T1 (de) | T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen | |
| DE69535855D1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
| ATE362939T1 (de) | Dimere von thrombinpeptidderivaten | |
| DK1551867T3 (da) | Anvendelse af poly-alfa-2,8-sialsyre-mimetiske peptider til modulering af NCAM-funktioner | |
| DE60033668D1 (de) | N-substituierte d-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation | |
| WO1994026903A3 (en) | Human influenza virus peptides binding hla-i molecule | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| DK0990703T3 (da) | Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf | |
| ATE554102T1 (de) | Therapeutische verwendungen von monoklonalen antikörpern gegen den angiotensin-ii typ-1 rezeptor | |
| Rohde et al. | Structure of antigenic determinants in the N-terminal region of dermatosparactic sheep procollagen type I | |
| ATE525470T1 (de) | Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen | |
| EP1679372A4 (en) | NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF | |
| HK1083850A1 (en) | Peptides binding the phosphatase 2a protein and polynucleotides encoding same | |
| BRPI0216042B8 (pt) | polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos. |